{"resourceType":"CodeSystem","id":"v3-substanceAdminSubstitution","language":"en","text":{"status":"generated","div":"<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p><b>Properties</b></p><p><b>This code system  defines the following properties for its concepts</b></p><table class=\"grid\"><tr><td><b>Code</b></td><td><b>URI</b></td><td><b>Type</b></td><td><b>Description</b></td></tr><tr><td>Specializes</td><td/><td>Coding</td><td>The child code is a more narrow version of the concept represented by the parent code.  I.e. Every child concept is also a valid parent concept.  Used to allow determination of subsumption.  Must be transitive, irreflexive, antisymmetric.</td></tr><tr><td>Generalizes</td><td/><td>Coding</td><td>Inverse of Specializes.  Only included as a derived relationship.</td></tr><tr><td>internalId</td><td>http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id</td><td>code</td><td>The internal identifier for the concept in the HL7 Access database repository.</td></tr><tr><td>notSelectable</td><td>http://hl7.org/fhir/concept-properties#notSelectable</td><td>boolean</td><td>Indicates that the code is abstract - only intended to be used as a selector for other concepts</td></tr><tr><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>code</td><td>Designation of a concept's state. Normally is not populated unless the state is retired.</td></tr></table><p><b>Concepts</b></p><p>This case-sensitive code system <code>http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution</code> defines the following codes in a Is-A heirarchy:</p><table class=\"codes\"><tr><td><b>Lvl</b></td><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>internalId</b></td><td><b>Not Selectable</b></td><td><b>status</b></td></tr><tr><td>1</td><td style=\"white-space:nowrap\">_ActSubstanceAdminSubstitutionCode<a name=\"v3-substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode\"> </a></td><td>ActSubstanceAdminSubstitutionCode</td><td><div><p><strong>Description:</strong> Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.</p>\n</div></td><td>21284</td><td>true</td><td>active</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">\u00a0\u00a0E<a name=\"v3-substanceAdminSubstitution-E\"> </a></td><td>equivalent</td><td><div><p><strong>Description:</strong> Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.</p>\n</div></td><td>23107</td><td/><td>active</td></tr><tr><td>3</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0EC<a name=\"v3-substanceAdminSubstitution-EC\"> </a></td><td>equivalent composition</td><td><div><p><strong>Description:</strong></p>\n<p>Substitution occurred or is permitted with another product that is a:</p>\n<ul>\n<li>pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester</li>\n<li>pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration</li>\n</ul>\n<p><em>Examples:</em></p>\n<ul>\n<li><em>Pharmaceutical alternative:</em> Erythromycin Ethylsuccinate for Erythromycin Stearate</li>\n<li><em>Pharmaceutical equivalent:</em> Lisonpril for Zestril</li>\n</ul>\n</div></td><td>23108</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0BC<a name=\"v3-substanceAdminSubstitution-BC\"> </a></td><td>brand composition</td><td><div><p><strong>Description:</strong></p>\n<p>Substitution occurred or is permitted between equivalent Brands but not Generics</p>\n<p><em>Examples:</em></p>\n<ul>\n<li>Zestril for Prinivil</li>\n<li>Coumadin for Jantoven</li>\n</ul>\n</div></td><td>23109</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0G<a name=\"v3-substanceAdminSubstitution-G\"> </a></td><td>generic composition</td><td><div><p><strong>Description:</strong> Substitution occurred or is permitted between equivalent Generics but not Brands</p>\n<p><em>Examples:</em></p>\n<ul>\n<li>Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)</li>\n</ul>\n</div></td><td>16623</td><td/><td>active</td></tr><tr><td>3</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0TE<a name=\"v3-substanceAdminSubstitution-TE\"> </a></td><td>therapeutic alternative</td><td><div><p><strong>Description:</strong> Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.</p>\n<p><em>Examples:</em></p>\n<ul>\n<li>ranitidine for Tagamet</li>\n</ul>\n</div></td><td>16624</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0TB<a name=\"v3-substanceAdminSubstitution-TB\"> </a></td><td>therapeutic brand</td><td><div><p><strong>Description:</strong> Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics</p>\n<blockquote>\n</blockquote>\n<p><em>Examples:</em></p>\n<ul>\n<li>Zantac for Tagamet</li>\n</ul>\n</div></td><td>23105</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0TG<a name=\"v3-substanceAdminSubstitution-TG\"> </a></td><td>therapeutic generic</td><td><div><p><strong>Description:</strong> Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands</p>\n<blockquote>\n</blockquote>\n<p><em>Examples:</em></p>\n<ul>\n<li>Ranitidine for cimetidine</li>\n</ul>\n</div></td><td>23106</td><td/><td>active</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">\u00a0\u00a0F<a name=\"v3-substanceAdminSubstitution-F\"> </a></td><td>formulary</td><td><div><p><strong>Description:</strong> This substitution was performed or is permitted based on formulary guidelines.</p>\n</div></td><td>16625</td><td/><td>active</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">\u00a0\u00a0N<a name=\"v3-substanceAdminSubstitution-N\"> </a></td><td>none</td><td><div><p>No substitution occurred or is permitted.</p>\n</div></td><td>16622</td><td/><td>active</td></tr></table></div>"},"url":"http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.5.1070"}],"version":"3.0.0","name":"SubstanceAdminSubstitution","title":"Substance Admin Substitution","status":"active","experimental":false,"date":"2019-03-20","publisher":"Health Level Seven International","contact":[{"telecom":[{"system":"url","value":"http://hl7.org"},{"system":"email","value":"hq@HL7.org"}]}],"description":"Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.","copyright":"This material derives from the HL7 Terminology THO. THO is copyright Â©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license","caseSensitive":true,"hierarchyMeaning":"is-a","content":"complete","property":[{"extension":[{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry","valueCode":"antisymmetric"},{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity","valueCode":"transitive"},{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity","valueCode":"irreflexive"},{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable","valueBoolean":true},{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind","valueCode":"Specializes"},{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName","valueString":"Generalizes"}],"code":"Specializes","description":"The child code is a more narrow version of the concept represented by the parent code.  I.e. Every child concept is also a valid parent concept.  Used to allow determination of subsumption.  Must be transitive, irreflexive, antisymmetric.","type":"Coding"},{"extension":[{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry","valueCode":"antisymmetric"},{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity","valueCode":"transitive"},{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity","valueCode":"irreflexive"},{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable","valueBoolean":true},{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind","valueCode":"Generalizes"},{"url":"http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName","valueString":"Specializes"}],"code":"Generalizes","description":"Inverse of Specializes.  Only included as a derived relationship.","type":"Coding"},{"code":"internalId","uri":"http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id","description":"The internal identifier for the concept in the HL7 Access database repository.","type":"code"},{"code":"notSelectable","uri":"http://hl7.org/fhir/concept-properties#notSelectable","description":"Indicates that the code is abstract - only intended to be used as a selector for other concepts","type":"boolean"},{"code":"status","uri":"http://hl7.org/fhir/concept-properties#status","description":"Designation of a concept's state. Normally is not populated unless the state is retired.","type":"code"}],"concept":[{"code":"_ActSubstanceAdminSubstitutionCode","display":"ActSubstanceAdminSubstitutionCode","definition":"**Description:** Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.","property":[{"code":"notSelectable","valueBoolean":true},{"code":"status","valueCode":"active"},{"code":"internalId","valueCode":"21284"}],"concept":[{"code":"E","display":"equivalent","definition":"**Description:** Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.","property":[{"code":"status","valueCode":"active"},{"code":"internalId","valueCode":"23107"}],"concept":[{"code":"EC","display":"equivalent composition","definition":"**Description:** \r\n\r\nSubstitution occurred or is permitted with another product that is a:\r\n\r\n *  pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester\r\n *  pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration\r\n\r\n*Examples:* \r\n\r\n *  *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate\r\n *  *Pharmaceutical equivalent:* Lisonpril for Zestril","property":[{"code":"status","valueCode":"active"},{"code":"internalId","valueCode":"23108"}],"concept":[{"code":"BC","display":"brand composition","definition":"**Description:** \r\n\r\nSubstitution occurred or is permitted between equivalent Brands but not Generics\r\n\r\n*Examples:* \r\n\r\n *  Zestril for Prinivil\r\n *  Coumadin for Jantoven","property":[{"code":"status","valueCode":"active"},{"code":"internalId","valueCode":"23109"}]},{"code":"G","display":"generic composition","definition":"**Description:** Substitution occurred or is permitted between equivalent Generics but not Brands\r\n\r\n*Examples:* \r\n\r\n *  Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)","property":[{"code":"status","valueCode":"active"},{"code":"internalId","valueCode":"16623"}]}]},{"code":"TE","display":"therapeutic alternative","definition":"**Description:** Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.\r\n\r\n*Examples:* \r\n\r\n *  ranitidine for Tagamet","property":[{"code":"status","valueCode":"active"},{"code":"internalId","valueCode":"16624"}],"concept":[{"code":"TB","display":"therapeutic brand","definition":"**Description:** Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics\r\n\r\n>\r\n\r\n*Examples:* \r\n\r\n *  Zantac for Tagamet","property":[{"code":"status","valueCode":"active"},{"code":"internalId","valueCode":"23105"}]},{"code":"TG","display":"therapeutic generic","definition":"**Description:** Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands\r\n\r\n>\r\n\r\n*Examples:* \r\n\r\n *  Ranitidine for cimetidine","property":[{"code":"status","valueCode":"active"},{"code":"internalId","valueCode":"23106"}]}]}]},{"code":"F","display":"formulary","definition":"**Description:** This substitution was performed or is permitted based on formulary guidelines.","property":[{"code":"status","valueCode":"active"},{"code":"internalId","valueCode":"16625"}]},{"code":"N","display":"none","definition":"No substitution occurred or is permitted.","property":[{"code":"status","valueCode":"active"},{"code":"internalId","valueCode":"16622"}]}]}]}